A detailed history of Caption Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Caption Management, LLC holds 10,000 shares of RGEN stock, worth $1.68 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$1.68 Million
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $838,530 - $1.17 Million
7,000 New
7,000 $1.04 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $2.91 Million - $3.79 Million
21,000 New
21,000 $2.97 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.32B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.